U.S. Congress legislation · 119th Congress
HB10544: Ovarian Cancer IMPACT Act
Status: In committee, September 24, 2026
To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
What the bill says
To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
From the introduced text, September 24, 2026:
A BILL To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes. SECTION 1. Short title This Act may be cited as the Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing Act or the Ovarian Cancer IMPACT Act . SECTION 2. Findings Congress finds the following: (1) Ovarian cancer remains one of the deadliest gynecologic cancers and is frequently diagnosed at an advanced stage. (2) Early recognition of symptoms, access to genetic counseling and testing, and timely referral to specialized care can improve outcomes for individuals diagnosed with ovarian cancer. (3) Significant disparities persist in access to gynecologic oncology services, genetic counseling, hereditary cancer risk assessment, and specialty care, particularly in rural and medically underserved communities. (4) Advances in genetic and genomic science present significant opportunities to improve prevention, early detection, treatment selection, and survivorship outcomes. (5) Hereditary cancer syndromes, including hereditary breast and ovarian cancer syndrome and Lynch syndrome, contribute significantly to ovarian cancer risk and may first be identified following a diagnosis of endometrial cancer. (6) Evidence-based genetic counseling and testing can inform treatment decisions, guide preventive interventions, and identify at-risk family members who may benefit from surveillance or risk-reducing care. (7) Increased public education, provider …
Sponsors
- Rosa DeLauro (D, HD-003) · primary sponsor
- Don Bacon (R, HD-NE-2)
- Balint, Becca (D, HD-000)
- Brian Fitzpatrick (R, HD-001)
- Eugene Vindman (D, HD-007)
Latest actions
- : Referred to the House Committee on Energy and Commerce.
- : Introduced in House
Subjects: Health
Common questions
- What is HB10544?
- HB10544 is a bill in Congress (119th Congress): Ovarian Cancer IMPACT Act.
- What does HB10544 do?
- In its own words: To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
- What is the status of HB10544?
- In committee as of September 24, 2026. Latest action: Referred to the House Committee on Energy and Commerce. (September 24, 2026).
- Who sponsored HB10544?
- Rosa DeLauro (D, HD-003), with 4 co-sponsors.
- Where is the official record for HB10544?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/10544
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.